Jump to navigation
Enter the article’s url One of our curators will take care of it as soon as possible!
Subscribe to our weekly newsletter.
Everipedia, a two-year-old online encyclopedia, will become a decentralized, peer-to-peer, user-owned resource.
Equifax aside, companies are doing better at securing their info. But the phishers keep coming.
Understanding that vaccines are critical to public health and human-driven carbon emissions are un-terraforming the planet cannot be the purview of the one percent.
This Thanksgiving, we bring you four portraits of immigrants in tech—from the C-Suite to the gig economy.
A new analysis says economics has problems with bias, reproducibility, and statistical power. You know, like all the other social sciences.
The Atlas humanoid robot from Boston Dynamics can now do backflips. That's one hell of a feat for a bipedal machine.
One of the biggest and best studies of alcohol's effects on health is underway. But funding from the alcohol industry is already undercutting its results.
The review of artificial intelligence argues a new AI council should be created but it wouldn't be in charge of regulating systems
When a scientific paper is retracted, it can produce long-term aftershocks.
More social scientists are using AI intending to solve society’s ills, but they don’t have clear ethical guidelines to prevent them from accidentally harming people.
It might just reinvent the entire medical publishing process.
A physics professor explains why male scientists devalue research that shows gender bias in the field.
Researchers planted a working hacker "exploit" in a physical strand of DNA.
In the past few months, three high-profile science conferences have ignited internet ire for their lack of representation of women.
The country desperately needs more egghead lawmakers. Right now, Capitol Hill has almost none.
Humanity might have saved itself a lot of trouble in the long run by investing in the Einstein-Szilard approach to cooling water with fire.
The Structural Genomics Consortium encourages pharma companies and academics to put all their cards on the table in the interest of speeding up drug research.
Posting scientific papers online, free to the public, seems like a great idea. But it's more complicated than it sounds.
Plagiarism. Cheating. Lying. Should these scientists get a second chance?